|
Faculty
Robert O. Dillman, M.D., F.A.C.P.
Hoag Cancer Center
Robert O. Dillman has been Medical Director of Hoag Cancer Center since 1989, overseeing inpatient and outpatient activity involving over 2000 new cancer cases each year, the largest cancer program in southern California outside of Los Angeles. As Director of Clinical and Laboratory Cancer Research, he oversees operation of a cell biology research laboratory, the high-dose chemotherapy/stem cell transplant program, and cancer clinical trials. Dr. Dillman personally applies his expertise to the center's work in cancer prevention, medical staff and community education, early detection of cancer, second opinion consultations, tumor case conferences, support services, and treatment with biological therapies.
Dr. Dillman earned a B.A. in psychology from Stanford University and M.D. from Baylor College of Medicine in Houston, Texas. He received postgraduate training at Baylor where he was chief resident of internal medicine, and subspecialty training at the University of California San Diego where he also was involved in immunology laboratory research. He is board certified in internal medicine, hematology, and medical oncology.
Dr. Dillman held faculty positions at the University of California, San Diego, where he was assistant director of the U.C.S.D. cancer center and chief of hematology/oncology at the San Diego VA Medical Center. Immediately prior to joining Hoag Hospital, he was director of experimental clinical oncology at the Scripps Clinic in La Jolla, California and associate director of the Ida M. Green Cancer Center of Scripps Clinic and Research Foundation and associate medical director for Biotherapeutics, Inc. In 1989 he also was named a Clinical Professor of Medicine at UC Irvine.
As a highly respected medical and scientific lecturer, Dr. Dillman has delivered more than 450 invited presentations. He has chaired numerous clinical trials and has authored or co-authored over 400 scientific articles and abstracts. These include prestigious review articles on the use of monoclonal antibodies for the treatment of cancer in the Annals of Internal Medicine and the Journal of Clinical Oncology, as well as landmark reports in the New England Journal of Medicine and the Journal of the National Cancer Institute describing improved survival in non-small cell lung cancer who received chemotherapy in addition to radiation therapy. He is also recognized internationally for his work in biological therapy including monoclonal antibodies, interleukin-2, adoptive cellular therapy and cancer vaccines.
Dr. Dillman is in his 4th consecutive term as chairman of the Cancer Biotherapy Research Group, served as president of the Inter-American Society for Chemotherapy and is the current president of the Society for Biological Therapy. He chaired the 9th Annual Meeting of the Society for Biological Therapy and the 3rd and 4th International Congress on Biological Response Modifiers. He also a past president of the Orange County Chapter of the American Cancer Society. In 1992 Dr. Dillman became the first medical oncologist or hematologist in Orange County, California to be selected by has peers as one of The Best Doctors in America, a prestigious listing published by Woodward & White. He has also been named as one of The Best Doctors in the Western Region, as one of the Top Doctors in Orange County, and his been listed in various Who's Who related to science and medicine.
Dr. Dillman and his wife Jacquelyn reside in Newport Beach and have raised six sons. She herself is a nationally renowned oncology nurse who in 1991 became the first Oncology Nursing Society recipient of the Schering Award for Excellence in Biotherapy. Dr. Dillman enjoys road trips to Stanford football games and golf, including international team match play at some of the most famous courses in England, Scotland, and Ireland.
Eli Gladstein, MD
University of Pennsylvania Medical Center
Leo I. Gordon, MD
Northwestern University Feinberg School of Medicine
Leo I. Gordon, MD, is the Abby and John Friend Professor of Cancer Research and Professor of Medicine, Northwestern University Medical School; Chief, Division of Hematology/Oncology and Associate Director for Clinical Sciences at the Robert H. Lurie Comprehensive Cancer Center of Northwestern. Dr. Gordon has been affiliated with Northwestern University Medical School since 1979.
As a clinician-scientist who specializes in hematology-oncology, Dr. Gordon's research interests include hematologic malignancies, breast cancer, biologic therapies and bone marrow transplantation. His laboratory is funded in part by a grant from the National Institutes of Health. He has a special interest in the biology and treatment of malignant lymphomas.
Dr. Gordon has served on committees of several national organizations and foundations related to cancer. He is currently the co-chairman of the Eastern Cooperative Oncology Group Lymphoma Committee.
Dr. Gordon is a member of the editorial boards of several peer-reviewed scientific journals. Dr. Gordon is a prolific author of reports, editorials, reviews, chapters, abstracts, and books.
Dr. Gordon received his MD degree with distinction from the University of Cincinnati and is a member of Alpha Omega Alpha. He completed internship and residency at the University of Chicago, and fellowship in Hematology and Medical Oncology at the University of Minnesota and University of Chicago.
Stephanie Ann Gregory, M.D.
Rush Medical Center, Chicago, Illinois
Dr. Gregory is Professor of Medicine at Rush Medical Center, Chicago, Illinois and the Elodia Kehm Professor and Director of Hematology at Rush-Presbyterian-St. Luke's Medical Center/Rush Cancer Institute, Chicago, Illinois. Dr. Gregory received her baccalaureate degree cum laude from Boston College and her M.D. degree cum laude from the Medical College of Pennsylvania/Hahnemann Medical School in Philadelphia, Pennsylvania. She served an internship, residency, and Chief Residency, all in internal medicine, at Rush-Presbyterian-St. Luke's Medical Center. She underwent three years of subspecialty training in hematology under a Schweppe Foundation Fellowship Award at Rush-Presbyterian-St. Luke's Medical Center. Dr. Gregory's career has been directed toward patient care, teaching, research and administration. She was elected to the "Mark H. Lepper, M.D. Society of Teachers" at Rush Medical College in 1986. She became the first woman to be appointed to the endowed chair as Director of Hematology at Rush in 1995. She was elected the first woman president of the Chicago Society of Internal Medicine from 1994 to 1995. In 1994 she traveled to Croatia as a member of the "United Nations Security Council Commission of Experts Investigating War Crimes and Sexual Assaults against Women in the Former Yugoslavia." She is a Fellow of the American College of Physicians, a member of the Northern Illinois Council of the College, and in 1996 received the "Illinois Laureate Award" from the College. She was awarded the "1998 Alumnae Achievement Award" by the Medical College of Pennsylvania/Hahnemann Medical School.
As Director of the Section of Hematology and Co-Director of the Lymphoma program at the Rush Cancer Institute, Dr. Gregory is involved in many investigative studies in leukemias, lymphomas, myelodysplastic syndromes, myelomas and other hematologic malignancies. She has authored or coauthored 312 manuscripts, book chapters and abstracts. Dr Gregory speaks extensively on hematologic malignancies.
Dr. Gregory is a member of the Advisory Boards of the Leukemia Research Foundation, Leukemia/Lymphoma Society of America and the Lymphoma Research Foundation. She is an active member of the American Society of Hematology, American Society of Clinical Oncology and numerous other medical professional associations. Dr. Gregory serves on many industrial boards and speaks extensively on her clinical research.
Russel Schilder, MD
Fox Chase Cancer Center
Russell J Schilder, M.D., is a member of the Department of Medical Oncology at the Fox Chase Cancer Center and an Associate Professor of Medicine at Temple University School of Medicine. He received his medical degree from the University of Miami and completed his internship and residency in internal medicine and a fellowship in hematology and oncology at Temple University Hospital and Fox Chase Cancer Center. Dr. Schilder is a member of a number of medical societies, including the American Society of Clinical Oncology, the American Society of Hematology, the American Society for Blood and Marrow Transplantation, the Society for Biologic Therapy, the American College of Physicians and the Eastern Cooperative Oncology Group. His research interests include gynecologic malignancies, hematologic malignancies, new drug development and high dose chemotherapy. He has written more than 100 book chapters, articles, and abstracts.
Stephen Schuster, MD
University of Pennsylvania Medical Center
|
